Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This blend combines two well-documented synthetic peptides commonly referenced in preclinical and laboratory research exploring cellular signalling, tissue-related pathways, and peptide stability within controlled research systems
During your visit, you can discuss your concerns and explore the best treatments for you
GHK-CU dosing by administration method Each delivery method has optimal dose ranges developed through clinical practice and research extrapolation
A combination of recombinant human apurinic/apyrimidinic endonuclease 1/redox factor 1 (rhAPE1/Ref-1) and aspirin synergistically induces cell death and apoptosis in ovarian cancer cells, particularly PEO14, and enhances paclitaxel-induced apoptosis, suggesting a novel approach to improving treatment outcomes
US$ 25.18
US$ 28.78
US$ 27.66
US$ 22.15
